The FDA’s own clinical data now sit in the peer-reviewed record showing a 155% higher risk of unexplained death, a 515% higher risk of disabling reactions, and an EXTREME risk-benefit imbalance.

***

Our reanalysis of the FDA clinical data used

The post BREAKING: Our FDA Data Reanalysis Demanding Market Withdrawal of Moderna’s mRNA Flu Shot is Now Peer-Reviewed and Published appeared first on Global Research.

Leave A Comment